Douglas Sato
Overview
Explore the profile of Douglas Sato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomes de Brito Ventura L, Solla D, Silva G, Salles L, Sato D, Pereira S, et al.
Clin Neurol Neurosurg
. 2025 Feb;
250:108787.
PMID: 39970773
Background: Optic neuritis (ON) is the leading cause of optic neuropathy among young adults. Approximately 45 % of these patients have autoantibodies, and their possible clinical and prognostic implications have...
2.
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodology
Alonso R, Rivera V, Carnero Contentti E, Hamuy Diaz de Bedoya V, Ciampi E, Silva B, et al.
Mult Scler Relat Disord
. 2025 Jan;
94:106244.
PMID: 39823690
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a serious condition affecting people worldwide, including Latin America (LATAM). Healthcare disparities and economic limitations make effective treatment access challenging. It is crucial...
3.
Rivera V, Hamuy F, Rivas V, Gracia F, Rojas J, Bichuetti D, et al.
Mult Scler Relat Disord
. 2021 Jun;
53:103083.
PMID: 34171682
Background: Neuromyelitis optica spectrum disorders (NMOSD) is an increasing diagnostic and therapeutic challenge in Latin America (LATAM). Despite the heterogeneity of this population, ethnic and socioeconomic commonalities exist, and epidemiologic...
4.
Di Pauli F, Hoftberger R, Reindl M, Beer R, Rhomberg P, Schanda K, et al.
Neurol Neuroimmunol Neuroinflamm
. 2015 Nov;
2(6):e175.
PMID: 26587556
Objectives: Antibodies to myelin oligodendrocyte glycoprotein (MOG) are detectable in inflammatory demyelinating CNS diseases, and MOG antibody-associated diseases seem to have a better prognosis despite occasionally severe presentations. Methods: We...
5.
Kremer S, Renard F, Achard S, Lana-Peixoto M, Palace J, Asgari N, et al.
JAMA Neurol
. 2015 May;
72(7):815-22.
PMID: 26010909
Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them...
6.
Sato D, Callegaro D, Lana-Peixoto M, Fujihara K
Arq Neuropsiquiatr
. 2012 Jan;
70(1):59-66.
PMID: 22218475
Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system characterized by severe optic neuritis and transverse myelitis, usually with a relapsing course. Aquaporin-4 antibody is positive in...
7.
Sato D, Fujihara K
Arq Neuropsiquiatr
. 2011 Nov;
69(5):824-8.
PMID: 22042189
Neuromyelitis optica (NMO) is an inflammatory disease of central nervous system classically characterized by acute, severe episodes of optic neuritis and longitudinally extensive transverse myelitis, usually with a relapsing course....
8.